日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prognostic value of Ki-67 index in malignant phyllodes tumor of the breast: a multi-center real-world study

Ki-67 指数在乳腺恶性叶状肿瘤中的预后价值:一项多中心真实世界研究

Zhou, Yiran; Guo, Changyuan; Wang, Yan; Xu, Hangcheng; Sa, Qiang; Che, Shunan; Chen, Shanshan; Lan, Bo; Luo, Yang; Wang, Jiani; Mo, Hongnan; Cai, Ruigang; Li, Qiao; Fan, Ying; Zhang, Pin; Ma, Fei; Xu, Binghe; Wang, Jiayu

Efficacy and safety of PARP inhibitors in metastatic breast cancer patients with homologous recombination repair pathway gene mutations: a retrospective multicenter real-world study

PARP抑制剂治疗携带同源重组修复通路基因突变的转移性乳腺癌患者的疗效和安全性:一项回顾性多中心真实世界研究

Peng, Xuenan; Song, Ruixia; Fan, Ying; Wang, Jiayu; Li, Qiao; Mo, Hongnan; Wang, Jiani; Luo, Yang; Chen, Shanshan; Sun, Xiaoying; Zhang, Jintao; Zhang, Pin; Xu, Binghe; Lan, Bo; Ma, Fei

Microstructure and Properties of Different Modulus Sections in JG4246A Alloy Characteristic Simulation Castings

JG4246A合金不同模量截面特征模拟铸件的微观结构和性能

Jiang, Hai-Tao; Jin, Lei; Jing, Gao-Yang; Li, Peng; Fan, Bing-Zheng; Li, Yi-Peng; Ma, Lan-Bo; Li, Ao-Qi; Liu, Tian-Yv; Sun, Xun; Guan, Yang

A Novel Sensitive Technique to Detect ESR1 Hotspot Mutations in Liquid Biopsy Using Switch-Blocker-Enhanced Targeted Amplification Coupled With Pyrosequencing

一种利用开关阻断剂增强靶向扩增结合焦磷酸测序技术检测液体活检中ESR1热点突变的新型灵敏技术

Zhou, Yantong; Wang, Wenna; Lan, Bo; Li, Chunxiao; Wang, Jinsong; Wang, Ting; Sun, Fangzhou; Wang, Yan; Qian, Haili; Ma, Fei

Oncology Health Management: From Educational Awareness to System Building

肿瘤健康管理:从教育意识到系统构建

Bao, Xinyue; Lan, Bo; Ma, Fei

Identification of Key Targets of Herbal Compounds for Liver Fibrosis Using Network Pharmacology Combined With Transcriptomics

利用网络药理学结合转录组学鉴定治疗肝纤维化的草药化合物的关键靶点

Chen, Chen; Huang, Bo; Hu, Mengting; Yang, Shengpeng; Lan, Bo; Cui, Dejun

High-Plex Digital Spatial Profiling Identified Prolactin-Induced Protein mRNA Associated With Response and Survival of Everolimus and Letrozole Treatment for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer

高通量数字空间分析鉴定出催乳素诱导蛋白mRNA与激素受体阳性/人表皮生长因子受体2阴性晚期乳腺癌患者接受依维莫司和来曲唑治疗的反应和生存率相关

Han, Yuhang; Ji, Danyang; Tan, Yujing; Wang, Jiayu; Ma, Fei; Luo, Yang; Lan, Bo; Zhang, Pin; Ying, Jianming; Xu, Binghe; Xue, Liyan; Fan, Ying

Exploration of the clonal evolution and construction of the tumor clonal evolution rate as a prognostic indicator in metastatic breast cancer

探索克隆演化并构建肿瘤克隆演化率作为转移性乳腺癌预后指标

Lv, Dan; Lan, Bo; Guo, Qihan; Yi, Zongbi; Qian, Haili; Guan, Yanfang; Peng, Xuenan; Chen, Ting; Ma, Fei

The ideal strategies of antibody‒drug conjugate sequential treatment in HER2-expressing metastatic breast cancer: A multi-center real-world study

抗体-药物偶联物序贯治疗HER2表达转移性乳腺癌的理想策略:一项多中心真实世界研究

Peng, Xuenan; Lan, Bo; Wang, Jiayu; Li, Qiao; Wang, Jiani; Fan, Ying; Luo, Yang; Chen, Shanshan; Mo, Hongnan; Li, Lixi; Sun, Xiaoying; Zhang, Jintao; Cai, Ruigang; Zhang, Pin; Xu, Binghe; Ma, Fei

Associations between dynamic hematological indicators and outcomes in HR-positive, HER2-negative metastatic breast cancer treated with bireociclib or placebo plus fulvestrant: Findings from the BRIGHT-2 trial

BRIGHT-2试验结果显示,在接受bireociclib或安慰剂联合氟维司群治疗的HR阳性、HER2阴性转移性乳腺癌患者中,动态血液学指标与预后之间的关联性:

Xu, Hangcheng; Wang, Yan; Sa, Qiang; Zhou, Yiran; Ma, Fei; Zhang, Pin; Fan, Ying; Cai, Ruigang; Li, Qiao; Lan, Bo; Wang, Jiani; Cui, Liang; Tan, Xinxin; Bai, Jing; Hu, Yan; Duan, Xianghui; Yang, Fan; Wang, Jiayu; Xu, Binghe